VP, DM1 Commercial Asset Lead

Role: Vice President, DM1 Commercial Asset Lead, responsible for developing and executing global commercialization strategies for Dyne's DM1 asset, supporting long-term market success. Core responsibilities include defining asset positioning, leading launch planning, coordinating cross-functional teams, and managing stakeholder engagement within the neuromuscular space. The role involves shaping market access, reimbursement strategies, and external relationships with KOLs, advocacy groups, and payers. Requirements: Bachelor's degree (advanced degree preferred), 20+ years in biopharma, with at least 15 years in commercialization and a track record of leading global product launches (minimum three). Experience in rare diseases, neuromuscular disorders, or similar therapeutic areas is highly preferred. Candidates should demonstrate strong leadership, strategic planning, stakeholder influence, and communication skills, with expertise in navigating regulatory and market access landscapes. High-value specifics include rare neuromuscular diseases (DMD, DM1), global launch experience, and patient-centric approach. The position is based onsite in Waltham, MA, with a focus on US and international markets.